
AHR Stock Forecast & Price Target
AHR Analyst Ratings
Bulls say
American Healthcare REIT is set to continue its positive trajectory, with over $2B of available liquidity and a strong track record in investments. Their recent forward equity issuance and ongoing active pipeline of deals indicate confidence in future growth opportunities. While regional headwinds may pose some risk, particularly in the skilled nursing housing segment, the company's solid balance sheet and strong performance in its integrated senior health campuses and outpatient medical segments provide a solid foundation for continued success.
Bears say
American Healthcare REIT is facing significant headwinds in the near-term due to higher G&A expenses, which are expected to offset any gains from increased NOI. Their SHOP segment has potential for upside if the summer leasing season performs strongly, but overall, their outlook for 2026 and 2027 is moderate. The company also has a basic ESG strategy, and given their current cost of capital and balance sheet, they will likely focus on acquiring their JV partner's Trilogy ownership stake and funding Trilogy related expansions or developments. However, there are several key risks, including a downturn in the healthcare industry and changes to regulations and supply pressures for skilled nursing and senior housing, that could negatively impact their performance in the future.
This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.
AHR Analyst Forecast & Price Prediction
Start investing in AHR
Order type
Buy in
Order amount
Est. shares
0 shares